Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature
A subset of non-small cell lung carcinoma (NSCC) harbor active mutations of epidermal growth factor receptor (EGFR). In these, EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as the first-line treatment. Though drug resistance is inevitable, histological transformation to small cell lung...
Main Authors: | Monalisa Hui, Shantveer G Uppin, Bala Joseph Stalin, G Sadashivudu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Lung India |
Subjects: | |
Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=2;spage=160;epage=163;aulast=Hui |
Similar Items
-
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future
by: Walid Shalata, et al.
Published: (2021-08-01) -
Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells
by: Jose Thaiparambil, et al.
Published: (2023-04-01) -
Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma
by: Ying-Yi Chen, et al.
Published: (2023-10-01) -
Role of gender in the survival of surgical patients with nonsmall cell lung cancer
by: Nóris C Scaglia, et al.
Published: (2013-01-01) -
Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications
by: Ranjan Pathak, et al.
Published: (2021-09-01)